Medical software BioVisor©

clinicalmanagementdiagnostic

This investigation line focuses on the acquisition of new products that allow the detection of virus, bacteria, fungi and parasites in a sensible and efficent way. We are currently putting great effort to develop detection systems for the bacteria resistances, as the appearance of organisms resistent to antibiotics is a first-rate healthy problem. Development of products for the study of genetic diseases This line of research has made possible the development of products that enables the detection of polymorphism related to genetic diseases, such as the thrombophilia, hemochromatosis and Alzheimer. This line of investigation has been realized in two product lines. On one hand the RealType line that inlcudes exclusive products of our company, and on the other hand the Thrombo inCode y Cardio inCode products jointly developped with Gendiag and Ferrer inCode. Development of new genetic diagnostic tests This line allows the incorporation of new genetic diseases in our catalogue. Thanks to the incorporation of the new generation sequencing (NGS) we are able to conduct de diagnostic of one hundred multigenic diseases through the study of selected genes panels. Software development Progenie molecular develops software called BioVisor©. BioVisor© NGS allows the study of mutations obtained through exome sequencing. BioVisor RealCycler and BioVisor RealType facilitate the interpretation of results obtained with the RealCycler products (pathogens detection and quantification) and the RealType products (genotyping through Real-Time PCR), respectively. We have also developped the Progestor software, that allows the management of clinical samples and their results.